TreatmentAgent
MS023 treatment (1.0 μM, 48.0h)

Treatment
released
View JSON

MS023 treatment to inhibit type I protein arginine methyltransferases (PRMTs)

   July 16th, 2020 at 5:09pm

Details

aliases 
  1. karla-neugebauer-lab:treatment_MS023
chemical 
MS023
concentration 
1
concentration_units 
μM
duration 
48
duration_units 
hour
public_release 
April 6th, 2021
treatment_type 
Chemical